| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chagas Disease | 22 | 2024 | 294 | 6.510 |
Why?
|
| Trypanosoma cruzi | 16 | 2024 | 236 | 5.810 |
Why?
|
| Pregnancy | 213 | 2025 | 7178 | 5.190 |
Why?
|
| Pregnancy Complications, Infectious | 19 | 2025 | 450 | 5.020 |
Why?
|
| Pregnancy Outcome | 46 | 2021 | 588 | 4.910 |
Why?
|
| Prenatal Care | 51 | 2022 | 347 | 3.950 |
Why?
|
| Cyclonic Storms | 13 | 2020 | 74 | 3.190 |
Why?
|
| Premature Birth | 27 | 2023 | 385 | 3.100 |
Why?
|
| Pregnancy Complications | 24 | 2017 | 512 | 2.990 |
Why?
|
| Infectious Disease Transmission, Vertical | 12 | 2021 | 241 | 2.910 |
Why?
|
| Disasters | 12 | 2017 | 102 | 2.860 |
Why?
|
| Developing Countries | 32 | 2023 | 270 | 2.790 |
Why?
|
| Immunogenicity, Vaccine | 3 | 2025 | 102 | 2.650 |
Why?
|
| Infant, Low Birth Weight | 30 | 2023 | 167 | 2.420 |
Why?
|
| Birth Weight | 30 | 2024 | 346 | 2.280 |
Why?
|
| Maternal Health Services | 13 | 2013 | 37 | 2.150 |
Why?
|
| Pregnancy Complications, Parasitic | 8 | 2024 | 25 | 2.120 |
Why?
|
| Female | 231 | 2025 | 66569 | 2.120 |
Why?
|
| Infant Mortality | 35 | 2020 | 174 | 2.120 |
Why?
|
| Infant, Newborn | 100 | 2024 | 8191 | 2.030 |
Why?
|
| Diabetes, Gestational | 6 | 2017 | 112 | 1.930 |
Why?
|
| Chikungunya Fever | 4 | 2025 | 27 | 1.860 |
Why?
|
| Zika Virus Infection | 7 | 2023 | 170 | 1.760 |
Why?
|
| Viral Vaccines | 3 | 2025 | 333 | 1.730 |
Why?
|
| Delivery, Obstetric | 21 | 2020 | 251 | 1.710 |
Why?
|
| Public Health | 8 | 2020 | 262 | 1.680 |
Why?
|
| Humans | 263 | 2025 | 124725 | 1.640 |
Why?
|
| Pregnant Women | 10 | 2022 | 142 | 1.620 |
Why?
|
| Louisiana | 19 | 2022 | 135 | 1.550 |
Why?
|
| Periodontal Diseases | 8 | 2015 | 25 | 1.540 |
Why?
|
| Vaccines | 4 | 2023 | 366 | 1.420 |
Why?
|
| Stress Disorders, Post-Traumatic | 11 | 2015 | 628 | 1.410 |
Why?
|
| Petroleum Pollution | 3 | 2021 | 4 | 1.330 |
Why?
|
| Syphilis | 5 | 2022 | 96 | 1.310 |
Why?
|
| Mental Health | 7 | 2014 | 344 | 1.290 |
Why?
|
| Global Health | 13 | 2018 | 560 | 1.280 |
Why?
|
| Antibodies, Protozoan | 6 | 2021 | 76 | 1.280 |
Why?
|
| Obstetric Labor, Premature | 15 | 2016 | 85 | 1.270 |
Why?
|
| Cesarean Section | 14 | 2020 | 387 | 1.210 |
Why?
|
| Lassa Fever | 2 | 2025 | 9 | 1.210 |
Why?
|
| Chikungunya virus | 2 | 2025 | 27 | 1.190 |
Why?
|
| Adult | 103 | 2024 | 29488 | 1.150 |
Why?
|
| Maternal Mortality | 19 | 2014 | 80 | 1.150 |
Why?
|
| Meta-Analysis as Topic | 6 | 2025 | 156 | 1.120 |
Why?
|
| Stress, Psychological | 6 | 2019 | 555 | 1.110 |
Why?
|
| Argentina | 25 | 2024 | 52 | 1.110 |
Why?
|
| Mothers | 9 | 2019 | 353 | 1.100 |
Why?
|
| Postpartum Hemorrhage | 10 | 2013 | 96 | 1.060 |
Why?
|
| Gestational Age | 26 | 2021 | 1158 | 1.020 |
Why?
|
| Mexico | 12 | 2024 | 183 | 1.010 |
Why?
|
| Zika Virus | 4 | 2023 | 143 | 1.000 |
Why?
|
| Nitroimidazoles | 3 | 2020 | 44 | 0.990 |
Why?
|
| Birth Rate | 3 | 2020 | 16 | 0.970 |
Why?
|
| Lassa virus | 1 | 2025 | 21 | 0.970 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 358 | 0.940 |
Why?
|
| Dengue | 4 | 2014 | 113 | 0.930 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 372 | 0.930 |
Why?
|
| Perinatal Mortality | 8 | 2013 | 43 | 0.930 |
Why?
|
| Socioeconomic Factors | 17 | 2019 | 870 | 0.910 |
Why?
|
| Parturition | 4 | 2024 | 62 | 0.890 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2023 | 225 | 0.890 |
Why?
|
| Depression, Postpartum | 5 | 2010 | 52 | 0.870 |
Why?
|
| Maternal Welfare | 6 | 2012 | 14 | 0.860 |
Why?
|
| Trypanosoma | 1 | 2023 | 10 | 0.850 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2024 | 63 | 0.840 |
Why?
|
| Young Adult | 44 | 2024 | 9023 | 0.840 |
Why?
|
| Environmental Exposure | 3 | 2017 | 220 | 0.840 |
Why?
|
| Microcephaly | 4 | 2021 | 330 | 0.830 |
Why?
|
| Belgium | 30 | 2020 | 43 | 0.810 |
Why?
|
| Periodontitis | 5 | 2013 | 11 | 0.800 |
Why?
|
| Parity | 11 | 2019 | 78 | 0.770 |
Why?
|
| Risk Factors | 42 | 2020 | 10286 | 0.760 |
Why?
|
| Maternal Exposure | 3 | 2022 | 148 | 0.750 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2021 | 822 | 0.750 |
Why?
|
| Stillbirth | 11 | 2016 | 80 | 0.750 |
Why?
|
| Craniosynostoses | 1 | 2023 | 133 | 0.740 |
Why?
|
| Women's Health | 5 | 2019 | 133 | 0.740 |
Why?
|
| Midwifery | 9 | 2019 | 41 | 0.730 |
Why?
|
| Adolescent | 50 | 2025 | 19284 | 0.730 |
Why?
|
| Perinatal Care | 5 | 2019 | 67 | 0.720 |
Why?
|
| Infant, Small for Gestational Age | 3 | 2019 | 57 | 0.710 |
Why?
|
| Population Surveillance | 8 | 2020 | 388 | 0.710 |
Why?
|
| Maternal Age | 9 | 2016 | 134 | 0.700 |
Why?
|
| Prospective Studies | 29 | 2021 | 6147 | 0.700 |
Why?
|
| Home Childbirth | 6 | 2013 | 39 | 0.670 |
Why?
|
| Logistic Models | 15 | 2019 | 1812 | 0.650 |
Why?
|
| Abortion, Spontaneous | 5 | 2017 | 79 | 0.650 |
Why?
|
| Vaccination | 7 | 2024 | 955 | 0.640 |
Why?
|
| Evidence-Based Medicine | 9 | 2016 | 634 | 0.630 |
Why?
|
| Metals | 1 | 2019 | 62 | 0.630 |
Why?
|
| Biomedical Research | 3 | 2020 | 519 | 0.630 |
Why?
|
| Fetal Blood | 7 | 2022 | 176 | 0.620 |
Why?
|
| Infant | 29 | 2023 | 12475 | 0.610 |
Why?
|
| Syphilis, Congenital | 4 | 2022 | 28 | 0.600 |
Why?
|
| Oxytocin | 5 | 2011 | 68 | 0.590 |
Why?
|
| Honduras | 6 | 2024 | 26 | 0.590 |
Why?
|
| Zambia | 9 | 2023 | 20 | 0.590 |
Why?
|
| Protozoan Vaccines | 1 | 2019 | 96 | 0.590 |
Why?
|
| Review Literature as Topic | 2 | 2008 | 43 | 0.570 |
Why?
|
| Depression | 5 | 2012 | 1223 | 0.570 |
Why?
|
| Public Health Administration | 1 | 2017 | 9 | 0.570 |
Why?
|
| Oxytocics | 4 | 2010 | 28 | 0.560 |
Why?
|
| Fertilization in Vitro | 2 | 2017 | 147 | 0.550 |
Why?
|
| Nausea | 1 | 2017 | 84 | 0.550 |
Why?
|
| Health Status | 3 | 2012 | 375 | 0.550 |
Why?
|
| Uruguay | 13 | 2023 | 15 | 0.550 |
Why?
|
| Risk Assessment | 8 | 2020 | 3447 | 0.540 |
Why?
|
| Disease Transmission, Infectious | 1 | 2017 | 84 | 0.540 |
Why?
|
| Health Services Accessibility | 10 | 2020 | 607 | 0.540 |
Why?
|
| Prevalence | 12 | 2020 | 2447 | 0.530 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2015 | 117 | 0.530 |
Why?
|
| Vomiting | 1 | 2017 | 105 | 0.530 |
Why?
|
| Infertility | 1 | 2017 | 76 | 0.530 |
Why?
|
| Smoking Cessation | 6 | 2016 | 198 | 0.520 |
Why?
|
| Glucocorticoids | 5 | 2016 | 381 | 0.520 |
Why?
|
| Surveys and Questionnaires | 15 | 2017 | 3716 | 0.520 |
Why?
|
| Birth Certificates | 5 | 2013 | 13 | 0.510 |
Why?
|
| Obstetrics | 8 | 2013 | 238 | 0.510 |
Why?
|
| Validation Studies as Topic | 1 | 2015 | 13 | 0.500 |
Why?
|
| Serologic Tests | 3 | 2021 | 118 | 0.500 |
Why?
|
| Apgar Score | 4 | 2020 | 47 | 0.490 |
Why?
|
| Maternal Health | 3 | 2021 | 20 | 0.480 |
Why?
|
| Poverty | 3 | 2014 | 422 | 0.480 |
Why?
|
| Perception | 2 | 2015 | 219 | 0.470 |
Why?
|
| Tropical Medicine | 2 | 2014 | 104 | 0.460 |
Why?
|
| Sleep Wake Disorders | 1 | 2017 | 167 | 0.460 |
Why?
|
| Indians, South American | 1 | 2014 | 14 | 0.460 |
Why?
|
| Encephalitis, St. Louis | 1 | 2014 | 20 | 0.460 |
Why?
|
| Pandemics | 4 | 2024 | 1102 | 0.450 |
Why?
|
| Emigration and Immigration | 6 | 2010 | 81 | 0.450 |
Why?
|
| Cross-Sectional Studies | 10 | 2024 | 3432 | 0.450 |
Why?
|
| Cohort Studies | 14 | 2023 | 4806 | 0.450 |
Why?
|
| Adaptation, Psychological | 3 | 2015 | 444 | 0.440 |
Why?
|
| Labor Stage, Third | 6 | 2011 | 6 | 0.440 |
Why?
|
| Acculturation | 5 | 2016 | 68 | 0.440 |
Why?
|
| Emigrants and Immigrants | 2 | 2012 | 144 | 0.430 |
Why?
|
| Research Design | 7 | 2025 | 693 | 0.430 |
Why?
|
| Postpartum Period | 4 | 2020 | 214 | 0.420 |
Why?
|
| Mexican Americans | 4 | 2017 | 204 | 0.420 |
Why?
|
| Health Knowledge, Attitudes, Practice | 8 | 2021 | 848 | 0.420 |
Why?
|
| Universities | 2 | 2017 | 125 | 0.420 |
Why?
|
| United States | 28 | 2022 | 10899 | 0.410 |
Why?
|
| Adrenal Cortex Hormones | 4 | 2016 | 317 | 0.410 |
Why?
|
| Disaster Planning | 3 | 2009 | 63 | 0.400 |
Why?
|
| Obstetric Labor Complications | 6 | 2019 | 93 | 0.400 |
Why?
|
| Periodontal Index | 4 | 2013 | 4 | 0.400 |
Why?
|
| Periodontal Pocket | 4 | 2013 | 5 | 0.400 |
Why?
|
| Periodontal Attachment Loss | 4 | 2013 | 6 | 0.400 |
Why?
|
| Social Class | 7 | 2017 | 190 | 0.400 |
Why?
|
| HIV Infections | 3 | 2020 | 1891 | 0.390 |
Why?
|
| Reproduction | 1 | 2014 | 236 | 0.390 |
Why?
|
| Delivery of Health Care | 5 | 2024 | 607 | 0.390 |
Why?
|
| Glucose Intolerance | 1 | 2012 | 78 | 0.390 |
Why?
|
| Child | 15 | 2025 | 24383 | 0.380 |
Why?
|
| Obesity | 2 | 2013 | 2245 | 0.380 |
Why?
|
| Schools, Public Health | 1 | 2011 | 5 | 0.380 |
Why?
|
| Safety Management | 2 | 2012 | 112 | 0.380 |
Why?
|
| Health Services Needs and Demand | 4 | 2020 | 174 | 0.380 |
Why?
|
| Schools, Medical | 1 | 2012 | 111 | 0.370 |
Why?
|
| Education, Graduate | 1 | 2011 | 20 | 0.370 |
Why?
|
| Internationality | 2 | 2016 | 131 | 0.370 |
Why?
|
| Educational Status | 8 | 2016 | 276 | 0.370 |
Why?
|
| Infant, Premature | 10 | 2018 | 812 | 0.370 |
Why?
|
| Patient Care Planning | 1 | 2012 | 121 | 0.370 |
Why?
|
| Emblems and Insignia | 1 | 2011 | 1 | 0.360 |
Why?
|
| Twins | 6 | 2002 | 69 | 0.360 |
Why?
|
| Competency-Based Education | 1 | 2011 | 69 | 0.360 |
Why?
|
| Perinatal Death | 3 | 2016 | 26 | 0.350 |
Why?
|
| Fetal Development | 2 | 2024 | 132 | 0.350 |
Why?
|
| Battered Women | 1 | 2010 | 5 | 0.350 |
Why?
|
| Infant Health | 2 | 2021 | 16 | 0.350 |
Why?
|
| Mississippi | 3 | 2020 | 33 | 0.350 |
Why?
|
| Spouse Abuse | 1 | 2010 | 16 | 0.340 |
Why?
|
| Pre-Eclampsia | 5 | 2010 | 221 | 0.340 |
Why?
|
| Misoprostol | 1 | 2010 | 26 | 0.330 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2013 | 314 | 0.330 |
Why?
|
| Odds Ratio | 11 | 2015 | 1259 | 0.330 |
Why?
|
| Child Health Services | 1 | 2011 | 86 | 0.330 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 4 | 2007 | 16 | 0.330 |
Why?
|
| Puerperal Infection | 3 | 2015 | 8 | 0.330 |
Why?
|
| Body Mass Index | 5 | 2013 | 1563 | 0.320 |
Why?
|
| Clinical Laboratory Techniques | 4 | 2020 | 142 | 0.320 |
Why?
|
| Income | 4 | 2022 | 133 | 0.320 |
Why?
|
| Crime Victims | 1 | 2010 | 58 | 0.320 |
Why?
|
| Periodicals as Topic | 1 | 2012 | 198 | 0.320 |
Why?
|
| Health Personnel | 5 | 2021 | 505 | 0.320 |
Why?
|
| Trypanocidal Agents | 2 | 2019 | 29 | 0.310 |
Why?
|
| Tobacco Smoke Pollution | 3 | 2016 | 76 | 0.310 |
Why?
|
| Hypertension | 2 | 2017 | 1323 | 0.310 |
Why?
|
| Relief Work | 1 | 2008 | 31 | 0.300 |
Why?
|
| Interpersonal Relations | 1 | 2010 | 228 | 0.300 |
Why?
|
| Social Support | 6 | 2012 | 345 | 0.300 |
Why?
|
| Smoking | 6 | 2016 | 1046 | 0.300 |
Why?
|
| Registries | 13 | 2018 | 1434 | 0.300 |
Why?
|
| Episiotomy | 5 | 2009 | 16 | 0.290 |
Why?
|
| Latin America | 9 | 2020 | 92 | 0.290 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2020 | 1111 | 0.290 |
Why?
|
| Health Status Disparities | 1 | 2010 | 227 | 0.290 |
Why?
|
| Contraceptives, Oral | 5 | 1991 | 37 | 0.290 |
Why?
|
| Diabetes Mellitus | 3 | 2012 | 872 | 0.290 |
Why?
|
| Mass Screening | 6 | 2021 | 782 | 0.270 |
Why?
|
| Case-Control Studies | 7 | 2016 | 3284 | 0.270 |
Why?
|
| Self Report | 4 | 2021 | 513 | 0.270 |
Why?
|
| Clinical Competence | 2 | 2011 | 999 | 0.270 |
Why?
|
| Counseling | 4 | 2015 | 217 | 0.260 |
Why?
|
| Seroepidemiologic Studies | 3 | 2015 | 122 | 0.260 |
Why?
|
| Africa South of the Sahara | 5 | 2018 | 115 | 0.250 |
Why?
|
| Pregnancy, Multiple | 5 | 2017 | 47 | 0.250 |
Why?
|
| Sensitivity and Specificity | 5 | 2020 | 2050 | 0.250 |
Why?
|
| Breech Presentation | 3 | 2020 | 20 | 0.250 |
Why?
|
| Gynecology | 2 | 1998 | 123 | 0.250 |
Why?
|
| Anxiety | 3 | 2016 | 941 | 0.250 |
Why?
|
| New Orleans | 3 | 2015 | 13 | 0.240 |
Why?
|
| Prenatal Diagnosis | 7 | 2021 | 597 | 0.240 |
Why?
|
| Middle Aged | 15 | 2017 | 26797 | 0.240 |
Why?
|
| Child Welfare | 1 | 2005 | 64 | 0.230 |
Why?
|
| Quality Improvement | 3 | 2019 | 640 | 0.230 |
Why?
|
| Menstrual Cycle | 1 | 2004 | 34 | 0.230 |
Why?
|
| Text Messaging | 2 | 2015 | 32 | 0.220 |
Why?
|
| Weight Gain | 1 | 2006 | 403 | 0.220 |
Why?
|
| Decision Making | 3 | 2017 | 655 | 0.220 |
Why?
|
| Follow-Up Studies | 6 | 2020 | 5161 | 0.210 |
Why?
|
| Rwanda | 1 | 2023 | 7 | 0.210 |
Why?
|
| West Nile Fever | 2 | 2016 | 139 | 0.210 |
Why?
|
| Mental Disorders | 1 | 2010 | 820 | 0.210 |
Why?
|
| Aluminum | 1 | 2023 | 11 | 0.210 |
Why?
|
| C-Peptide | 1 | 2003 | 113 | 0.210 |
Why?
|
| Morbidity | 2 | 2022 | 247 | 0.210 |
Why?
|
| Antibodies, Neutralizing | 2 | 2025 | 468 | 0.210 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2008 | 729 | 0.210 |
Why?
|
| Fetal Growth Retardation | 2 | 2024 | 239 | 0.210 |
Why?
|
| Data Accuracy | 1 | 2023 | 25 | 0.210 |
Why?
|
| Uganda | 1 | 2023 | 79 | 0.210 |
Why?
|
| Pediatrics | 1 | 2012 | 1166 | 0.200 |
Why?
|
| Male | 23 | 2024 | 61269 | 0.200 |
Why?
|
| Delivery Rooms | 2 | 2013 | 17 | 0.200 |
Why?
|
| Democratic Republic of the Congo | 7 | 2019 | 14 | 0.200 |
Why?
|
| Quality of Health Care | 6 | 2010 | 390 | 0.200 |
Why?
|
| Incidence | 7 | 2021 | 3142 | 0.200 |
Why?
|
| Awareness | 2 | 2021 | 79 | 0.200 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2016 | 422 | 0.190 |
Why?
|
| Health Promotion | 2 | 2010 | 389 | 0.190 |
Why?
|
| Comorbidity | 4 | 2020 | 1531 | 0.190 |
Why?
|
| Neonatology | 3 | 2013 | 53 | 0.190 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2003 | 341 | 0.190 |
Why?
|
| Trichomonas vaginalis | 1 | 2021 | 9 | 0.190 |
Why?
|
| Trichomonas Vaginitis | 1 | 2021 | 13 | 0.190 |
Why?
|
| Retrospective Studies | 13 | 2020 | 16335 | 0.190 |
Why?
|
| Multivariate Analysis | 5 | 2016 | 1435 | 0.190 |
Why?
|
| Antibodies, Viral | 3 | 2025 | 1151 | 0.180 |
Why?
|
| History, 21st Century | 2 | 2012 | 267 | 0.180 |
Why?
|
| Europe | 6 | 2003 | 353 | 0.180 |
Why?
|
| Asymptomatic Diseases | 1 | 2021 | 83 | 0.180 |
Why?
|
| Child Development | 1 | 2023 | 267 | 0.180 |
Why?
|
| Extraction, Obstetrical | 1 | 2001 | 9 | 0.180 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2021 | 31 | 0.180 |
Why?
|
| Adjuvants, Immunologic | 1 | 2023 | 381 | 0.180 |
Why?
|
| Treponema pallidum | 1 | 2021 | 49 | 0.180 |
Why?
|
| Hospitals | 3 | 2013 | 389 | 0.180 |
Why?
|
| Observation | 1 | 2001 | 42 | 0.180 |
Why?
|
| Guideline Adherence | 5 | 2013 | 382 | 0.180 |
Why?
|
| History, 20th Century | 2 | 2012 | 383 | 0.180 |
Why?
|
| Alabama | 1 | 2020 | 46 | 0.180 |
Why?
|
| Parasite Load | 1 | 2020 | 31 | 0.180 |
Why?
|
| Health Information Systems | 1 | 2021 | 32 | 0.170 |
Why?
|
| Professional-Patient Relations | 2 | 2015 | 84 | 0.170 |
Why?
|
| Motivation | 3 | 2015 | 316 | 0.170 |
Why?
|
| Dimensional Measurement Accuracy | 1 | 2019 | 4 | 0.170 |
Why?
|
| Cephalometry | 1 | 2019 | 33 | 0.170 |
Why?
|
| Maternal-Child Health Services | 1 | 2019 | 13 | 0.170 |
Why?
|
| Quality Assurance, Health Care | 4 | 2019 | 206 | 0.160 |
Why?
|
| Cadmium | 1 | 2019 | 29 | 0.160 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2021 | 178 | 0.160 |
Why?
|
| Mercury | 1 | 2019 | 28 | 0.160 |
Why?
|
| Pregnancy Rate | 2 | 2017 | 31 | 0.160 |
Why?
|
| Fetus | 2 | 2023 | 585 | 0.160 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 2895 | 0.160 |
Why?
|
| Placenta | 1 | 2003 | 506 | 0.160 |
Why?
|
| Cerebral Palsy | 1 | 2001 | 79 | 0.160 |
Why?
|
| Bias | 6 | 2006 | 131 | 0.160 |
Why?
|
| Dried Blood Spot Testing | 1 | 2019 | 21 | 0.160 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 235 | 0.160 |
Why?
|
| Stress, Physiological | 1 | 2001 | 254 | 0.160 |
Why?
|
| Regression Analysis | 4 | 2010 | 778 | 0.160 |
Why?
|
| North Carolina | 5 | 2006 | 59 | 0.160 |
Why?
|
| Africa | 7 | 2016 | 133 | 0.160 |
Why?
|
| World Health Organization | 2 | 2018 | 101 | 0.150 |
Why?
|
| Diagnosis | 2 | 2016 | 29 | 0.150 |
Why?
|
| Viral Plaque Assay | 1 | 2018 | 42 | 0.150 |
Why?
|
| Pregnancy Trimester, First | 4 | 2013 | 114 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 6 | 2016 | 1269 | 0.150 |
Why?
|
| Residence Characteristics | 5 | 2010 | 278 | 0.150 |
Why?
|
| Infant, Premature, Diseases | 2 | 2011 | 242 | 0.150 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 502 | 0.150 |
Why?
|
| Labor, Obstetric | 3 | 1995 | 94 | 0.150 |
Why?
|
| Fetal Membranes, Premature Rupture | 3 | 2021 | 61 | 0.150 |
Why?
|
| Rural Population | 3 | 2015 | 256 | 0.150 |
Why?
|
| Databases, Factual | 1 | 2023 | 1178 | 0.150 |
Why?
|
| Marital Status | 3 | 2009 | 33 | 0.150 |
Why?
|
| Disease Outbreaks | 2 | 2024 | 320 | 0.150 |
Why?
|
| Mentors | 1 | 2019 | 148 | 0.150 |
Why?
|
| Gulf of Mexico | 1 | 2017 | 4 | 0.140 |
Why?
|
| Neutralization Tests | 1 | 2018 | 237 | 0.140 |
Why?
|
| Fertilization | 1 | 2017 | 42 | 0.140 |
Why?
|
| Neglected Diseases | 1 | 2020 | 151 | 0.140 |
Why?
|
| Focus Groups | 4 | 2021 | 198 | 0.140 |
Why?
|
| Congenital Abnormalities | 3 | 2016 | 254 | 0.140 |
Why?
|
| Phylogeny | 1 | 2019 | 697 | 0.140 |
Why?
|
| Pregnancy in Adolescence | 2 | 2015 | 50 | 0.140 |
Why?
|
| Intrauterine Devices | 2 | 1995 | 14 | 0.130 |
Why?
|
| Epidemiologic Methods | 3 | 1995 | 110 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 287 | 0.130 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2017 | 34 | 0.130 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 429 | 0.130 |
Why?
|
| Evaluation Studies as Topic | 2 | 2015 | 256 | 0.130 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 2156 | 0.130 |
Why?
|
| England | 2 | 2012 | 60 | 0.130 |
Why?
|
| Epidemiologic Research Design | 1 | 2016 | 4 | 0.130 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 479 | 0.130 |
Why?
|
| Feasibility Studies | 5 | 2017 | 760 | 0.130 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 2877 | 0.130 |
Why?
|
| Pregnancy, Twin | 2 | 2014 | 180 | 0.130 |
Why?
|
| Intensive Care, Neonatal | 1 | 2016 | 53 | 0.130 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 663 | 0.130 |
Why?
|
| Research Report | 1 | 2016 | 75 | 0.130 |
Why?
|
| Cetylpyridinium | 1 | 2015 | 1 | 0.130 |
Why?
|
| Patient Preference | 1 | 2017 | 118 | 0.130 |
Why?
|
| Perineum | 2 | 1987 | 48 | 0.130 |
Why?
|
| Oral Health | 1 | 2015 | 17 | 0.130 |
Why?
|
| Fear | 1 | 2017 | 199 | 0.130 |
Why?
|
| Mouthwashes | 1 | 2015 | 10 | 0.130 |
Why?
|
| Qualitative Research | 5 | 2021 | 542 | 0.130 |
Why?
|
| Communication | 2 | 2017 | 516 | 0.130 |
Why?
|
| Checklist | 1 | 2016 | 85 | 0.130 |
Why?
|
| Guatemala | 5 | 2014 | 62 | 0.130 |
Why?
|
| Data Collection | 4 | 2021 | 381 | 0.120 |
Why?
|
| Pakistan | 5 | 2014 | 75 | 0.120 |
Why?
|
| Attitude to Health | 2 | 2009 | 256 | 0.120 |
Why?
|
| Menstruation | 2 | 2007 | 29 | 0.120 |
Why?
|
| Tetanus Toxoid | 2 | 1995 | 45 | 0.120 |
Why?
|
| Nonlinear Dynamics | 1 | 1995 | 51 | 0.120 |
Why?
|
| India | 5 | 2014 | 214 | 0.120 |
Why?
|
| Clinical Coding | 1 | 2015 | 13 | 0.120 |
Why?
|
| Body Weights and Measures | 1 | 2015 | 42 | 0.120 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2015 | 71 | 0.120 |
Why?
|
| Child, Preschool | 6 | 2019 | 14018 | 0.120 |
Why?
|
| Health Education | 1 | 2016 | 221 | 0.120 |
Why?
|
| Africa, Northern | 4 | 2004 | 9 | 0.120 |
Why?
|
| Intention | 1 | 2015 | 92 | 0.120 |
Why?
|
| Influenza, Human | 1 | 2021 | 658 | 0.120 |
Why?
|
| Leadership | 1 | 2017 | 229 | 0.120 |
Why?
|
| Medication Adherence | 1 | 2019 | 397 | 0.120 |
Why?
|
| Cotinine | 1 | 2014 | 23 | 0.120 |
Why?
|
| Tetanus | 1 | 1995 | 21 | 0.120 |
Why?
|
| Wounds and Injuries | 2 | 2011 | 372 | 0.120 |
Why?
|
| Tobacco Use Disorder | 1 | 2015 | 89 | 0.120 |
Why?
|
| France | 6 | 2006 | 80 | 0.110 |
Why?
|
| Southeastern United States | 1 | 2014 | 36 | 0.110 |
Why?
|
| Cervix Uteri | 1 | 1994 | 64 | 0.110 |
Why?
|
| Health Behavior | 2 | 2009 | 385 | 0.110 |
Why?
|
| Analgesia, Obstetrical | 1 | 1994 | 8 | 0.110 |
Why?
|
| Education, Public Health Professional | 1 | 2014 | 5 | 0.110 |
Why?
|
| Dental Prophylaxis | 1 | 2013 | 2 | 0.110 |
Why?
|
| Tropical Climate | 1 | 2014 | 49 | 0.110 |
Why?
|
| Breast Feeding | 1 | 2015 | 219 | 0.110 |
Why?
|
| Infertility, Male | 1 | 2017 | 262 | 0.110 |
Why?
|
| Tobacco Use Cessation | 1 | 2013 | 4 | 0.110 |
Why?
|
| Health Surveys | 3 | 2010 | 241 | 0.110 |
Why?
|
| Sleep | 1 | 2017 | 343 | 0.110 |
Why?
|
| Kenya | 4 | 2014 | 52 | 0.110 |
Why?
|
| Infant Care | 2 | 2010 | 46 | 0.110 |
Why?
|
| Life Change Events | 2 | 2004 | 57 | 0.110 |
Why?
|
| Thinness | 1 | 2013 | 70 | 0.110 |
Why?
|
| Epidemics | 1 | 2013 | 54 | 0.110 |
Why?
|
| Immunization | 1 | 1995 | 307 | 0.110 |
Why?
|
| Hospitals, Public | 3 | 2010 | 42 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2016 | 309 | 0.110 |
Why?
|
| Sex Education | 1 | 1993 | 20 | 0.100 |
Why?
|
| Professional Competence | 1 | 2014 | 95 | 0.100 |
Why?
|
| Rubella | 2 | 1983 | 21 | 0.100 |
Why?
|
| Altitude | 1 | 2013 | 23 | 0.100 |
Why?
|
| Gingival Hemorrhage | 1 | 2012 | 1 | 0.100 |
Why?
|
| Gingival Recession | 1 | 2012 | 2 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 369 | 0.100 |
Why?
|
| AIDS Serodiagnosis | 1 | 2013 | 56 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 806 | 0.100 |
Why?
|
| Health Communication | 1 | 2012 | 26 | 0.100 |
Why?
|
| Prejudice | 2 | 2003 | 38 | 0.100 |
Why?
|
| Family Planning Services | 2 | 1989 | 37 | 0.100 |
Why?
|
| Time Factors | 7 | 2016 | 6308 | 0.100 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 208 | 0.100 |
Why?
|
| Puerto Rico | 3 | 2016 | 45 | 0.100 |
Why?
|
| Asia | 3 | 2016 | 107 | 0.100 |
Why?
|
| Antiprotozoal Agents | 1 | 2012 | 37 | 0.100 |
Why?
|
| Pregnancy Complications, Hematologic | 2 | 2003 | 28 | 0.100 |
Why?
|
| Healthcare Disparities | 2 | 2021 | 431 | 0.090 |
Why?
|
| Referral and Consultation | 3 | 2006 | 541 | 0.090 |
Why?
|
| Fasting | 1 | 2012 | 295 | 0.090 |
Why?
|
| Patient Compliance | 1 | 2014 | 472 | 0.090 |
Why?
|
| Insulin-Secreting Cells | 1 | 2012 | 148 | 0.090 |
Why?
|
| History, 15th Century | 1 | 2011 | 14 | 0.090 |
Why?
|
| Developed Countries | 1 | 2011 | 37 | 0.090 |
Why?
|
| Health Services Research | 3 | 2008 | 188 | 0.090 |
Why?
|
| Endemic Diseases | 2 | 2008 | 55 | 0.090 |
Why?
|
| Dexamethasone | 1 | 2012 | 276 | 0.090 |
Why?
|
| Uterus | 1 | 2015 | 569 | 0.090 |
Why?
|
| Community Networks | 1 | 2010 | 33 | 0.090 |
Why?
|
| Fetal Death | 2 | 2010 | 112 | 0.090 |
Why?
|
| Drug Utilization | 3 | 2016 | 160 | 0.090 |
Why?
|
| Mother-Child Relations | 2 | 2010 | 77 | 0.090 |
Why?
|
| Cause of Death | 6 | 2010 | 474 | 0.090 |
Why?
|
| Inservice Training | 1 | 2010 | 55 | 0.090 |
Why?
|
| Medical Staff, Hospital | 1 | 2010 | 93 | 0.090 |
Why?
|
| Finland | 6 | 2006 | 42 | 0.080 |
Why?
|
| Nursing Methodology Research | 1 | 2009 | 13 | 0.080 |
Why?
|
| Insurance, Dental | 1 | 2009 | 1 | 0.080 |
Why?
|
| Neoplasms | 3 | 2016 | 2788 | 0.080 |
Why?
|
| Rural Health | 2 | 2016 | 50 | 0.080 |
Why?
|
| Dental Care | 1 | 2009 | 8 | 0.080 |
Why?
|
| Health Planning | 1 | 1989 | 15 | 0.080 |
Why?
|
| Oral Hygiene | 1 | 2009 | 9 | 0.080 |
Why?
|
| Interviews as Topic | 3 | 2016 | 374 | 0.080 |
Why?
|
| Ultrasonography | 3 | 1991 | 929 | 0.080 |
Why?
|
| Sexual Partners | 1 | 2010 | 87 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2010 | 285 | 0.080 |
Why?
|
| Perinatology | 1 | 1990 | 32 | 0.080 |
Why?
|
| Body Weight | 1 | 2013 | 990 | 0.080 |
Why?
|
| Primary Prevention | 1 | 2011 | 171 | 0.080 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 712 | 0.080 |
Why?
|
| Drug Prescriptions | 2 | 1991 | 221 | 0.080 |
Why?
|
| Community Health Workers | 1 | 1989 | 66 | 0.080 |
Why?
|
| Preventive Health Services | 2 | 2006 | 60 | 0.080 |
Why?
|
| Curriculum | 2 | 2011 | 729 | 0.080 |
Why?
|
| Umbilical Cord | 1 | 2009 | 56 | 0.080 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2010 | 171 | 0.080 |
Why?
|
| Cultural Characteristics | 2 | 2004 | 41 | 0.080 |
Why?
|
| Genotype | 1 | 2015 | 2556 | 0.080 |
Why?
|
| Epidemiologic Studies | 2 | 2016 | 43 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 590 | 0.080 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2008 | 53 | 0.080 |
Why?
|
| Sampling Studies | 2 | 2003 | 77 | 0.080 |
Why?
|
| Blood Chemical Analysis | 1 | 1988 | 80 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2012 | 1136 | 0.070 |
Why?
|
| Emergency Medical Services | 1 | 2013 | 437 | 0.070 |
Why?
|
| Resuscitation | 1 | 2010 | 250 | 0.070 |
Why?
|
| Anemia | 2 | 2003 | 338 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2012 | 635 | 0.070 |
Why?
|
| Health Care Surveys | 2 | 2013 | 287 | 0.070 |
Why?
|
| Insulin | 1 | 2012 | 1203 | 0.070 |
Why?
|
| Hospital Departments | 1 | 1987 | 14 | 0.070 |
Why?
|
| Urban Population | 3 | 2015 | 225 | 0.070 |
Why?
|
| Alcohol Drinking | 1 | 2009 | 343 | 0.070 |
Why?
|
| Education, Medical, Continuing | 1 | 2008 | 140 | 0.070 |
Why?
|
| Aid to Families with Dependent Children | 1 | 2006 | 1 | 0.070 |
Why?
|
| Maternal-Child Health Centers | 1 | 2006 | 6 | 0.070 |
Why?
|
| French Guiana | 2 | 2018 | 2 | 0.070 |
Why?
|
| North America | 1 | 2007 | 239 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2011 | 1189 | 0.070 |
Why?
|
| China | 4 | 2015 | 243 | 0.070 |
Why?
|
| Analysis of Variance | 2 | 2006 | 1016 | 0.070 |
Why?
|
| Food Services | 1 | 2006 | 39 | 0.070 |
Why?
|
| Meperidine | 1 | 2006 | 8 | 0.060 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2007 | 74 | 0.060 |
Why?
|
| Labor Pain | 1 | 2006 | 3 | 0.060 |
Why?
|
| Animals | 6 | 2021 | 34024 | 0.060 |
Why?
|
| Massachusetts | 3 | 2016 | 126 | 0.060 |
Why?
|
| Private Practice | 1 | 1986 | 22 | 0.060 |
Why?
|
| Pregnancy, High-Risk | 3 | 2006 | 43 | 0.060 |
Why?
|
| Age Distribution | 2 | 2006 | 415 | 0.060 |
Why?
|
| Acid-Base Equilibrium | 1 | 2006 | 59 | 0.060 |
Why?
|
| Risk | 4 | 2013 | 755 | 0.060 |
Why?
|
| Hospitals, Maternity | 3 | 2011 | 8 | 0.060 |
Why?
|
| Information Dissemination | 1 | 2008 | 186 | 0.060 |
Why?
|
| Texas | 1 | 2014 | 3585 | 0.060 |
Why?
|
| Neonatal Screening | 1 | 2007 | 184 | 0.060 |
Why?
|
| Vagina | 2 | 1990 | 194 | 0.060 |
Why?
|
| Homicide | 1 | 2005 | 31 | 0.060 |
Why?
|
| Dengue Virus | 2 | 2018 | 127 | 0.060 |
Why?
|
| Elective Surgical Procedures | 1 | 2006 | 160 | 0.060 |
Why?
|
| ROC Curve | 2 | 2018 | 570 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2006 | 202 | 0.060 |
Why?
|
| Research | 2 | 2001 | 263 | 0.060 |
Why?
|
| Acidosis | 1 | 2006 | 93 | 0.060 |
Why?
|
| Anthropometry | 2 | 2016 | 199 | 0.060 |
Why?
|
| Vaccines, Attenuated | 1 | 2025 | 174 | 0.060 |
Why?
|
| Problem Solving | 1 | 2004 | 63 | 0.060 |
Why?
|
| Papio | 1 | 1983 | 60 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 2 | 2020 | 509 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 2428 | 0.050 |
Why?
|
| Health Facilities | 2 | 2016 | 60 | 0.050 |
Why?
|
| Retroviridae | 1 | 1983 | 198 | 0.050 |
Why?
|
| Receptors, Virus | 1 | 1983 | 107 | 0.050 |
Why?
|
| Cardiovascular Diseases | 3 | 2011 | 1952 | 0.050 |
Why?
|
| Netherlands | 2 | 1997 | 38 | 0.050 |
Why?
|
| Suicide | 1 | 2005 | 169 | 0.050 |
Why?
|
| Urban Health | 1 | 2003 | 76 | 0.050 |
Why?
|
| Organ Size | 1 | 2003 | 425 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2006 | 475 | 0.050 |
Why?
|
| Aged | 1 | 2020 | 19764 | 0.050 |
Why?
|
| Postnatal Care | 2 | 2012 | 51 | 0.050 |
Why?
|
| California | 1 | 2022 | 128 | 0.050 |
Why?
|
| Environment | 1 | 2002 | 145 | 0.050 |
Why?
|
| Epigenomics | 1 | 2022 | 163 | 0.050 |
Why?
|
| Statistics as Topic | 4 | 1995 | 256 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2006 | 417 | 0.050 |
Why?
|
| Pharmacovigilance | 1 | 2021 | 10 | 0.050 |
Why?
|
| Reference Values | 1 | 2002 | 711 | 0.050 |
Why?
|
| Models, Biological | 1 | 2006 | 1458 | 0.050 |
Why?
|
| Age Factors | 4 | 2015 | 2820 | 0.050 |
Why?
|
| Saliva | 2 | 2014 | 114 | 0.050 |
Why?
|
| Health Status Indicators | 2 | 2007 | 122 | 0.040 |
Why?
|
| Antigens, Viral | 2 | 2018 | 439 | 0.040 |
Why?
|
| Canada | 1 | 2001 | 286 | 0.040 |
Why?
|
| Causality | 2 | 2004 | 83 | 0.040 |
Why?
|
| Pregnancy, Ectopic | 2 | 2004 | 23 | 0.040 |
Why?
|
| Clinical Protocols | 2 | 2012 | 240 | 0.040 |
Why?
|
| Chagas Cardiomyopathy | 1 | 2020 | 48 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2001 | 237 | 0.040 |
Why?
|
| Minority Groups | 1 | 2022 | 248 | 0.040 |
Why?
|
| Forecasting | 2 | 2020 | 351 | 0.040 |
Why?
|
| Labor Stage, Second | 2 | 2010 | 16 | 0.040 |
Why?
|
| Birthing Centers | 1 | 2019 | 10 | 0.040 |
Why?
|
| Life Style | 1 | 2003 | 413 | 0.040 |
Why?
|
| Non-Randomized Controlled Trials as Topic | 1 | 2019 | 13 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2021 | 174 | 0.040 |
Why?
|
| Health Plan Implementation | 1 | 2019 | 42 | 0.040 |
Why?
|
| Genotyping Techniques | 1 | 2019 | 103 | 0.040 |
Why?
|
| Penicillin G Benzathine | 1 | 2019 | 18 | 0.040 |
Why?
|
| Asia, Southeastern | 1 | 2018 | 20 | 0.040 |
Why?
|
| Labor Stage, First | 2 | 2010 | 7 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2001 | 359 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2019 | 196 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2006 | 1089 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 1284 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 330 | 0.040 |
Why?
|
| Haplotypes | 1 | 2019 | 522 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2018 | 192 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 677 | 0.040 |
Why?
|
| Switzerland | 1 | 1997 | 15 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2013 | 1391 | 0.030 |
Why?
|
| Patient Selection | 1 | 2001 | 695 | 0.030 |
Why?
|
| Physician's Role | 1 | 1998 | 166 | 0.030 |
Why?
|
| Exons | 1 | 2019 | 796 | 0.030 |
Why?
|
| Government Agencies | 1 | 2016 | 11 | 0.030 |
Why?
|
| Needs Assessment | 2 | 2011 | 176 | 0.030 |
Why?
|
| Community Health Centers | 1 | 2016 | 39 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2022 | 1006 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 436 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2019 | 1586 | 0.030 |
Why?
|
| House Calls | 1 | 2015 | 38 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2017 | 227 | 0.030 |
Why?
|
| Publishing | 1 | 2016 | 110 | 0.030 |
Why?
|
| Puerperal Disorders | 1 | 2015 | 45 | 0.030 |
Why?
|
| Smoking Prevention | 1 | 2015 | 37 | 0.030 |
Why?
|
| Behavior Therapy | 1 | 2017 | 254 | 0.030 |
Why?
|
| Colposcopy | 1 | 1994 | 13 | 0.030 |
Why?
|
| Hospitals, District | 2 | 2006 | 6 | 0.030 |
Why?
|
| Students | 1 | 2017 | 248 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 240 | 0.030 |
Why?
|
| Obstetrical Forceps | 1 | 1994 | 8 | 0.030 |
Why?
|
| Self Efficacy | 1 | 2015 | 197 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 1995 | 231 | 0.030 |
Why?
|
| Anesthesia, Epidural | 1 | 1994 | 14 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 1707 | 0.030 |
Why?
|
| Abortion, Induced | 2 | 2004 | 74 | 0.030 |
Why?
|
| Models, Educational | 1 | 2014 | 74 | 0.030 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2013 | 10 | 0.030 |
Why?
|
| Blood Banks | 1 | 2013 | 12 | 0.030 |
Why?
|
| Nurse Midwives | 1 | 2013 | 9 | 0.030 |
Why?
|
| Consensus | 1 | 2016 | 646 | 0.030 |
Why?
|
| Contraindications | 1 | 1993 | 78 | 0.030 |
Why?
|
| Cell Phone | 1 | 2013 | 28 | 0.030 |
Why?
|
| Transients and Migrants | 1 | 1993 | 23 | 0.030 |
Why?
|
| Fetal Mortality | 1 | 2012 | 7 | 0.030 |
Why?
|
| United Kingdom | 1 | 1993 | 189 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2014 | 214 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1328 | 0.020 |
Why?
|
| Feedback | 1 | 1993 | 164 | 0.020 |
Why?
|
| Attitude | 1 | 2012 | 115 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 1993 | 143 | 0.020 |
Why?
|
| Scotland | 1 | 1991 | 17 | 0.020 |
Why?
|
| Periodontics | 1 | 2011 | 3 | 0.020 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2004 | 104 | 0.020 |
Why?
|
| Civil Defense | 1 | 2010 | 8 | 0.020 |
Why?
|
| Injections | 1 | 2011 | 154 | 0.020 |
Why?
|
| Information Systems | 2 | 1989 | 36 | 0.020 |
Why?
|
| Antigens, Protozoan | 1 | 2010 | 66 | 0.020 |
Why?
|
| Appointments and Schedules | 1 | 1990 | 49 | 0.020 |
Why?
|
| Uterine Hemorrhage | 1 | 2010 | 43 | 0.020 |
Why?
|
| Magnesium Sulfate | 1 | 2010 | 49 | 0.020 |
Why?
|
| Internet | 1 | 2013 | 375 | 0.020 |
Why?
|
| Hematologic Tests | 1 | 1990 | 35 | 0.020 |
Why?
|
| Birth Injuries | 1 | 1990 | 22 | 0.020 |
Why?
|
| Traction | 1 | 2009 | 9 | 0.020 |
Why?
|
| Telemedicine | 1 | 2015 | 434 | 0.020 |
Why?
|
| Emergencies | 1 | 2010 | 171 | 0.020 |
Why?
|
| Placenta, Retained | 1 | 2009 | 12 | 0.020 |
Why?
|
| Fetal Macrosomia | 1 | 2009 | 20 | 0.020 |
Why?
|
| Medically Underserved Area | 1 | 1990 | 90 | 0.020 |
Why?
|
| Temperament | 1 | 2009 | 24 | 0.020 |
Why?
|
| Sex Factors | 2 | 1990 | 1287 | 0.020 |
Why?
|
| Contraception | 1 | 1989 | 57 | 0.020 |
Why?
|
| Oxygen | 1 | 2013 | 553 | 0.020 |
Why?
|
| Psychology, Child | 1 | 2009 | 44 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2010 | 119 | 0.020 |
Why?
|
| Teaching | 1 | 2010 | 190 | 0.020 |
Why?
|
| Bolivia | 1 | 2008 | 15 | 0.020 |
Why?
|
| Health Services Misuse | 1 | 1988 | 26 | 0.020 |
Why?
|
| Sutures | 1 | 2009 | 65 | 0.020 |
Why?
|
| Resilience, Psychological | 1 | 2010 | 71 | 0.020 |
Why?
|
| Japan | 1 | 1989 | 133 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 1990 | 176 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2010 | 222 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 1101 | 0.020 |
Why?
|
| Decision Trees | 1 | 1988 | 49 | 0.020 |
Why?
|
| Pregnancy Trimester, Second | 1 | 1988 | 165 | 0.020 |
Why?
|
| Defensive Medicine | 1 | 2007 | 8 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2010 | 375 | 0.020 |
Why?
|
| Dermatitis, Contact | 1 | 1987 | 7 | 0.020 |
Why?
|
| Hypersensitivity, Immediate | 1 | 1987 | 16 | 0.020 |
Why?
|
| Nicotine | 1 | 2008 | 143 | 0.020 |
Why?
|
| Medical Records | 1 | 2007 | 192 | 0.020 |
Why?
|
| Physicians | 1 | 2013 | 581 | 0.020 |
Why?
|
| Benin | 1 | 2006 | 2 | 0.020 |
Why?
|
| Women, Working | 1 | 1986 | 9 | 0.020 |
Why?
|
| Women | 1 | 1986 | 15 | 0.020 |
Why?
|
| State Government | 1 | 2006 | 29 | 0.020 |
Why?
|
| Survival Rate | 1 | 2010 | 2047 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2006 | 105 | 0.020 |
Why?
|
| Medical Audit | 1 | 2006 | 102 | 0.020 |
Why?
|
| Death Certificates | 1 | 2004 | 9 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2006 | 432 | 0.010 |
Why?
|
| Medical Record Linkage | 1 | 2004 | 10 | 0.010 |
Why?
|
| International Classification of Diseases | 1 | 2005 | 90 | 0.010 |
Why?
|
| Nutrition Surveys | 1 | 2006 | 293 | 0.010 |
Why?
|
| Aftercare | 1 | 2006 | 147 | 0.010 |
Why?
|
| Seizures | 1 | 1990 | 872 | 0.010 |
Why?
|
| Menarche | 1 | 1984 | 35 | 0.010 |
Why?
|
| Adsorption | 1 | 1983 | 32 | 0.010 |
Why?
|
| Chiroptera | 1 | 1983 | 13 | 0.010 |
Why?
|
| Haplorhini | 1 | 1983 | 123 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2006 | 309 | 0.010 |
Why?
|
| Virus Cultivation | 1 | 1983 | 76 | 0.010 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2004 | 61 | 0.010 |
Why?
|
| Hospitals, Rural | 1 | 2003 | 9 | 0.010 |
Why?
|
| Rubella Vaccine | 1 | 1983 | 2 | 0.010 |
Why?
|
| Health Priorities | 1 | 2003 | 36 | 0.010 |
Why?
|
| Health Care Reform | 1 | 2003 | 50 | 0.010 |
Why?
|
| Body Height | 1 | 1984 | 215 | 0.010 |
Why?
|
| Dogs | 1 | 1983 | 768 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2006 | 332 | 0.010 |
Why?
|
| Eclampsia | 1 | 2000 | 29 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2000 | 113 | 0.010 |
Why?
|
| Insurance, Health | 1 | 2001 | 138 | 0.010 |
Why?
|
| Pregnancy Trimesters | 1 | 2000 | 34 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1983 | 1018 | 0.010 |
Why?
|
| Rats | 1 | 1983 | 3675 | 0.010 |
Why?
|
| Greece | 1 | 1995 | 11 | 0.010 |
Why?
|
| MEDLINE | 1 | 1995 | 20 | 0.010 |
Why?
|
| Sweden | 1 | 1995 | 34 | 0.010 |
Why?
|
| Indonesia | 1 | 1995 | 17 | 0.010 |
Why?
|
| Italy | 1 | 1995 | 97 | 0.010 |
Why?
|
| Norway | 1 | 1995 | 20 | 0.010 |
Why?
|
| Mice | 1 | 1983 | 17577 | 0.000 |
Why?
|
| Cost Control | 1 | 1986 | 24 | 0.000 |
Why?
|
| Allergens | 1 | 1987 | 252 | 0.000 |
Why?
|
| Object Attachment | 1 | 1985 | 49 | 0.000 |
Why?
|